CYNOCAN 12 INJ.2ML

What is CYNOCAN 12 INJ.2ML?

CYNOCAN 12 Injection contains Cytarabine (12 mg/2 ml), an antimetabolite chemotherapy medicine. It works by interfering with the DNA synthesis of rapidly dividing cancer cells, slowing or stopping their growth. It is usually given as an injection under medical supervision in hospitals or cancer centers.

---

What is the use of CYNOCAN 12 INJ.2ML?

• Treatment of blood cancers such as:

  • Acute Myeloid Leukemia (AML)

  • Acute Lymphocytic Leukemia (ALL)

  • Chronic Myeloid Leukemia (CML – blast crisis)

• Treatment of lymphomas like Non-Hodgkin’s Lymphoma.

• Sometimes used in meningeal leukemia (leukemia involving the brain and spinal cord).

---

Benefits of CYNOCAN 12 INJ.2ML

• Highly effective in treating aggressive blood cancers.

• Helps control abnormal cell growth and spread.

• Improves chances of remission in leukemia and lymphoma.

• Can be used alone or in combination with other chemotherapy drugs.

• Plays a vital role in induction, consolidation, and maintenance therapy in leukemia.

---

Side Effects of CYNOCAN 12 INJ.2ML

Common side effects:

• Nausea, vomiting, diarrhea

• Loss of appetite

• Mouth sores

• Fever or infections (due to low white blood cell count)

• Tiredness, weakness

Serious side effects (require immediate medical care):

• Severe bone marrow suppression (low RBC, WBC, platelets)

• Liver or kidney problems

• Lung complications (breathing difficulty, cough)

• Neurological effects (headache, dizziness, confusion at high doses)

• Bleeding, bruising easily

1. What is CYNOCAN 12 INJ.2ML used for?

It is used in the treatment of blood cancers like acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), chronic myeloid leukemia (CML – blast crisis), and some types of lymphomas.

2. How does CYNOCAN 12 INJ.2ML work?

Cytarabine, the active ingredient, blocks DNA synthesis in rapidly growing cancer cells, thereby slowing or stopping their growth.

3. How is CYNOCAN 12 INJ.2ML given?

It is given by a doctor or nurse through intravenous (IV), subcutaneous, or intrathecal injection depending on the treatment plan.

4. Can I take CYNOCAN 12 INJ.2ML at home?

No. This medicine must only be given in a hospital or cancer care center under oncologist supervision.

5. What are the common side effects?

Nausea, vomiting, diarrhea, loss of appetite, mouth ulcers, tiredness, fever, and low blood counts are common.

6. What serious side effects should I watch for?

Unusual bleeding, severe infections, breathing difficulty, confusion, liver/kidney issues, or chest pain require immediate medical care.

7. Does CYNOCAN 12 INJ.2ML affect blood counts?

Yes. It can lower white blood cells, red blood cells, and platelets, increasing the risk of infections, anemia, and bleeding.

8. Can pregnant women take CYNOCAN 12 INJ?

No. It may harm the unborn baby. Women should avoid pregnancy during treatment and use effective contraception.

9. Can I breastfeed while on CYNOCAN 12 INJ?

No. Cytarabine passes into breast milk and may harm the infant. Breastfeeding should be avoided.

10. Will I need regular tests while on CYNOCAN 12 INJ?

Yes. Frequent blood tests and organ function monitoring are required to track treatment safety and response.

11. Can CYNOCAN 12 INJ cause hair loss?

Yes. Temporary hair loss or thinning may occur, but hair usually grows back after treatment ends.

12. How long is treatment with CYNOCAN 12 INJ?

The duration depends on the type of cancer, treatment cycle, and doctor’s recommendation. It may be used in induction, consolidation, or maintenance therapy.